tiprankstipranks

Anthony Quinn Insider Profile

11 Followers
Anthony Quinn, EVP, CMO, & Head of R&D at Synageva, holds 161.33K shares in Generation Bio (Ticker: GBIO), holds 816.84K shares in Spyre Therapeutics (Ticker: SYRE), holds 31.60K shares in Kaleido Biosciences (Ticker: KLDO). Most recently, Anthony Quinn Bought ― shares of Generation Bio on Dec 05, 2023 for an estimated value of 124.78K.
tipranks
Anthony Quinn

Anthony Quinn
Synageva (GEVA)
EVP, CMO, & Head of R&D

Ranked #22,425 out of 99,635 Corporate Insiders

Profitable Transactions

78%
7 out of 9 Profitable Transactions

Average Return

+5.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$23M
99.01%
0.98%
<0.01%
A breakdown of Anthony Quinn's holdings

Insider Roles

Spyre Therapeutics
(SYRE)
President & CEO, Director
Generation Bio
(GBIO)
Director
Kaleido Biosciences
(KLDO)
Director
Roles that Anthony Quinn holds in companies

Most Profitable Insider Trade

Stock:
Spyre Therapeutics
(SYRE)
Rating:Informative Buy
Date:Dec 05, 2017 - Dec 05, 2018
Return:+71.00%
The most profitable trade made by Anthony Quinn

Anthony Quinn's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GEVA
Synageva
Jun 23, 2015
Uninformative Buy
3.00K
Spyre Therapeutics
Mar 18, 2022
President & CEO, Director
Informative Buy
187.38K
$22.72M
Kaleido Biosciences
Mar 04, 2019
Director
Uninformative Buy
$2.21K
Generation Bio
Dec 05, 2023
Director
Informative Buy
124.78K
$225.86K
List of latest transactions for each holding click on a transaction to see Anthony Quinn's performance on stock

Anthony Quinn insider profile FAQ

What is the percentage of profitable transactions made by Anthony Quinn?
The percentage of profitable transactions made by Anthony Quinn is 78%.
    What is the average return per transaction made by Anthony Quinn?
    The average return per transaction made by Anthony Quinn is 5.90%.
      What stocks does Anthony Quinn hold?
      Anthony Quinn holds: GEVA, SYRE, KLDO, GBIO stocks.
        What was Anthony Quinn’s latest transaction?
        Anthony Quinn latest transaction was an Informative Buy of $124.78K.
          What was Anthony Quinn's most profitable transaction?
          Anthony Quinn’s most profitable transaction was an Informative Buy of SYRE stock on December 5, 2017. The return on the trade was 71.00%.
            What is Anthony Quinn's role in Synageva?
            Anthony Quinn's role in Synageva is EVP, CMO, & Head of R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.